Search Results

Aloxistatin 25 mg  | 99.47%

TargetMol

Aloxistatin is an inhibitor of cysteine protease with blood platelet aggregation inhibiting activity. Aloxistatin is an irreversible, membrane-permeable inhibitor of lysosomal and cytosolic cysteine proteases with the ability to inhibit calpain activity in intact platelets.

More Information Supplier Page

Aloxistatin 5 mg  | 99.47%

TargetMol

Aloxistatin is an inhibitor of cysteine protease with blood platelet aggregation inhibiting activity. Aloxistatin is an irreversible, membrane-permeable inhibitor of lysosomal and cytosolic cysteine proteases with the ability to inhibit calpain activity in intact platelets.

More Information Supplier Page

BMH-21 5 mg  | 99.47%

TargetMol

BMH-21, a small molecule DNA intercalator, binds ribosomal DNA and inhibits RNA polymerase I (Pol I) transcription and not affects phosphorylation of H2AX.

More Information Supplier Page

BMH-21 25 mg  | 99.47%

TargetMol

BMH-21, a small molecule DNA intercalator, binds ribosomal DNA and inhibits RNA polymerase I (Pol I) transcription and not affects phosphorylation of H2AX.

More Information Supplier Page

BMH-21 100 mg  | 99.47%

TargetMol

BMH-21, a small molecule DNA intercalator, binds ribosomal DNA and inhibits RNA polymerase I (Pol I) transcription and not affects phosphorylation of H2AX.

More Information Supplier Page

BMH-21 200 mg  | 99.47%

TargetMol

BMH-21, a small molecule DNA intercalator, binds ribosomal DNA and inhibits RNA polymerase I (Pol I) transcription and not affects phosphorylation of H2AX.

More Information Supplier Page

Raddeanin A 25 mg  | 99.05%

TargetMol

Raddeanin A has moderate inhibitory activity against histone deacetylases (HDACs). Raddeanin A has high antiangiogenic potency, antitumor activity.

More Information Supplier Page